BMO Capital Starts ARMO BioSciences, Inc. (ARMO) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall St indexes fall to two-week lows as rising bond yields, disappointing Walmart results drag
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
Jefferies Starts ARMO BioSciences, Inc. (ARMO) at Buy
February 20, 2018 2:23 AM ESTJefferies initiates coverage on ARMO BioSciences, Inc. (NASDAQ: ARMO) with a Buy rating and a price target of $61.00.
For an analyst ratings summary and ratings history on ARMO BioSciences, Inc. click here. For more ratings news on ARMO BioSciences, Inc. click here.
Shares of ARMO BioSciences, Inc. closed at $53.65 Friday.
... MoreBaird Starts ARMO BioSciences, Inc. (ARMO) at Outperform
February 20, 2018 1:57 AM ESTBaird initiates coverage on ARMO BioSciences, Inc. (NASDAQ: ARMO) with a Outperform rating and a price target of $67.00.
Analyst Brian Skorney comments "We see ARMO's pegylated, recombinant IL-10, AM0010, as a unique asset in the IO space. It has shown singleagent response... More
